Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11725975rdf:typepubmed:Citationlld:pubmed
pubmed-article:11725975lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:11725975lifeskim:mentionsumls-concept:C0021852lld:lifeskim
pubmed-article:11725975lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:11725975lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:11725975lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:11725975lifeskim:mentionsumls-concept:C0234402lld:lifeskim
pubmed-article:11725975lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:11725975lifeskim:mentionsumls-concept:C0337184lld:lifeskim
pubmed-article:11725975lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:11725975lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:11725975lifeskim:mentionsumls-concept:C0021838lld:lifeskim
pubmed-article:11725975lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:11725975pubmed:issue11lld:pubmed
pubmed-article:11725975pubmed:dateCreated2001-11-29lld:pubmed
pubmed-article:11725975pubmed:abstractTextWe previously reported that small intestinal motility was significantly inhibited by restraint stress, but not by footshock stress. In the present study, we found that plasma beta-endorphin levels were more significantly elevated by footshock stress than restraint stress, and that preloading of footshock stimulus canceled the inhibition of small intestinal motility by restraint stress. Pretreatment with the mu-opioid receptor antagonist naltrexone significantly attenuated this canceling effect of footshock stimulus. These results suggest that footshock stimulus may cancel the inhibition of small intestinal motility by restraint stress via activation of mu-opioid receptors.lld:pubmed
pubmed-article:11725975pubmed:languageenglld:pubmed
pubmed-article:11725975pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11725975pubmed:citationSubsetIMlld:pubmed
pubmed-article:11725975pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11725975pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11725975pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11725975pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11725975pubmed:statusMEDLINElld:pubmed
pubmed-article:11725975pubmed:monthNovlld:pubmed
pubmed-article:11725975pubmed:issn0918-6158lld:pubmed
pubmed-article:11725975pubmed:authorpubmed-author:KohnoHHlld:pubmed
pubmed-article:11725975pubmed:authorpubmed-author:SugawaraMMlld:pubmed
pubmed-article:11725975pubmed:authorpubmed-author:OhkuboYYlld:pubmed
pubmed-article:11725975pubmed:authorpubmed-author:TsukadaFFlld:pubmed
pubmed-article:11725975pubmed:authorpubmed-author:OhuchiYYlld:pubmed
pubmed-article:11725975pubmed:authorpubmed-author:TerunumaTTlld:pubmed
pubmed-article:11725975pubmed:issnTypePrintlld:pubmed
pubmed-article:11725975pubmed:volume24lld:pubmed
pubmed-article:11725975pubmed:ownerNLMlld:pubmed
pubmed-article:11725975pubmed:authorsCompleteYlld:pubmed
pubmed-article:11725975pubmed:pagination1332-4lld:pubmed
pubmed-article:11725975pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:meshHeadingpubmed-meshheading:11725975...lld:pubmed
pubmed-article:11725975pubmed:year2001lld:pubmed
pubmed-article:11725975pubmed:articleTitleActivation of mu-opioid pathway is associated with the canceling effect of footshock stimulus on the restraint stress-induced inhibition of small intestinal motility in rats.lld:pubmed
pubmed-article:11725975pubmed:affiliationDepartment of Radiopharmacv, Tohoku Pharmaceutical University, Sendai, Japan.lld:pubmed
pubmed-article:11725975pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11725975lld:pubmed